http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd
Management, body systems, and case studies in COVID-19
Describes the assessment and treatment of patients infected with the novel coronavirus that causes the varied symptoms of COVID-19. Detailing this multisystem disease and the organs and tissues affected, this volume features chapters on several body systems. Conditions affecting the respiratory, hematological, hepatobiliary, renal, gastrointestinal, nervous, musculoskeletal, and cardiovascular systems are addressed. The fundamental role of telemedicine during the pandemic is also discussed. This volume is relevant for all clinicians and scientists working to ensure the best outcomes for patients with COVID-19.
Intro -- Management, Body Systems, and Case Studies in COVID-19 -- Copyright -- Dedication -- Contents -- Contributors -- Preface -- Section A: Introductory chapters and setting the scene -- Chapter 1: Hand hygiene strategies -- Introduction -- Soaps -- Types of soaps -- Classification by chemical synthesis: Soaps and syndets -- Classification by type of surfactant -- Classification by commercial presentation -- Effectiveness of soap in hand hygiene -- Adverse skin manifestations related to soaps -- Hand sanitizers -- Types of hand sanitizers
Effectiveness of hand sanitizers in hand hygiene -- Adverse skin manifestations related to hand sanitizers -- Comparison between soaps and hand sanitizers -- Impact of COVID-19 on hand hygiene -- Changes in hand hygiene products during COVID-19 -- Social awareness -- Skin manifestations -- Policies and procedures -- Applications to other areas -- Mini-dictionary of terms -- Summary points -- References -- Chapter 2: Approved vaccines for the COVID-19 pandemic: Linking in future perspectives -- Introduction -- Rapid COVID-19 vaccine development -- Current and most common COVID-19 Vaccines
Vaccination strategies to fight against variants of concern -- The versatility of mRNA platform for vaccine development and the emergence of variants of concerns (VoCs) -- Strategies for new vaccine development -- Alternative routes of vaccine administration -- Intranasal vaccine -- Other mucosal routes of vaccination -- Policies -- Applications to other areas -- Mini-dictionary of terms -- Summary points -- References -- Chapter 3: Molecular methods for SARS-CoV-2 variant detection -- Introduction -- Sequencing methods for detection of SARS-CoV-2 variants
Next-generation sequencing (NGS) technology -- NGS target enrichment -- Shotgun metagenomic sequencing -- Sanger sequencing -- PCR-based methods for detection of SARS-CoV-2 variants -- Reverse transcription quantitative PCR (RT-qPCR) -- Reverse transcription fluorescence resonance energy transfer polymerase chain reaction (RT-FRET-PCR) -- Allele-specific polymerase chain reaction (ASP) -- High-resolution melting (HRM) assay -- LAMP assay -- Reverse transcription-recombinase polymerase amplification (RT-RPA) -- RT-ddPCR (reverse transcriptase droplet digital PCR) -- CRISPR-Cas-based detection
Protein-based variant SARS-CoV-2 detection -- Antigen-based detection -- Antibody-based detection -- Mass spectrometry -- Conclusions and perspectives -- Mini-dictionary of terms -- Summary points -- References -- Section B: Management -- Chapter 4: Systematic patient assessment for acute respiratory tract ailments (SPARTA): A simple tool to improve outcomes ... -- Introduction -- Collaborative approach to quality improvement, training, and patient safety -- The challenge of following guidelines during an evolving pandemic
edited by Rajkumar Rajendram, Victor R. Preedy, Vinood B. Patel, Colin R. Martin.
Includes bibliographical references and index.